May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amol Akhade highlights key trials on neoadjuvant chemotherapy in pancreatic cancer
May 8, 2025, 16:44

Amol Akhade highlights key trials on neoadjuvant chemotherapy in pancreatic cancer

Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared on X:

“Neoadjuvant chemo in Pancreatic Cancer: Which trial favors what?
We compared
  • PANACHE01 (just out in Journal of Clinical Oncology)
  • SWOG S1505
  • NORPACT-1
Only NORPACT-1 favored upfront surgery
Others showed feasibility and OS gain with NAC
Checkout both slides below.”

Amol Akhade

Title: Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)

Journal: Journal of Clinical Oncology

Authors: Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, Olivier Bouché, Eric Assenat, Guillaume Piessen, Pascal Hammel, Nicolas Regenet, Julien Taieb, Olivier Turrini, Francois Paye, Anthony Turpin, Francois-Regis Souche, Christophe Laurent, Reza Kianmanesh, Pierre Michel, Dewi Vernerey, Jean-Yves Mabrut, Celia Turco, Stephanie Truant, Antonio Sa Cunha

Read the full article.

Amol Akhade

Learn more about Amol Akhade on OncoDaily.